Craig Woods, DVM, MS, MBA



  • DVM – 1995 – University of Missouri
  • MS – 1995, Veterinary Anatomy – University of Missouri
  • MBA – 2003 – Arizona State University

Clinical Interests

  • Antivenoms, antitoxins, venom pathophysiology
  • Biological scaffolds, tissue regeneration, stem cells
  • Immunotherapeutics (cancer, infection, immune mediated disease)
  • Phase II-IV human clinical trials
  • Comparative and translational veterinary trials

As Director of the IHI, Dr. Woods uses his 15+ years of clinical research and industry experience to advance therapeutics and diagnostics for veterinary and human medicine.  His approach to clinical research takes into account the potential clinical benefit, plus other factors such as regulatory affairs, financial feasibility, and production costs. As such, his overall goal is to see clinical research projects translate into eventual patient availability, and therefore make a difference in the lives of animals and people

From 1995 until 1998, Dr. Woods was in small animal practice. In 1998, he entered industry where he held various senior level positions for pharmaceutical companies located in the US, Mexico, and France. Dr. Woods has a background in clinical trials, project management, regulatory affairs, due diligence, and business development, and has led numerous technology licensing transactions for life science companies.  As a clinical research scientist, he has conducted clinical trials in ophthalmology, envenomation, regenerative medicine, infectious disease, and immune mediated conditions.  Dr. Woods has presented original research at various medical conferences, and published in the Journal of Rheumatology, Journal of Veterinary Emergency and Critical Care, and Toxicon. Craig has been a licensed veterinarian in Arizona since 1995.